Blood Donors on Teratogenic Drugs and Donor Deferral Periods in a Clinical Situation

    December 2011 in “ Vox Sanguinis ”
    Soo Youn Shin, Young Hack Shin, S. W. Lee … C. H. Kim
    Studysummary This study found that blood samples from donors on teratogenic drugs sometimes exceeded recommended concentration limits, suggesting a need for improved deferral policies.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Blood Donors on Medication: An Approach to Minimize Drug Burden for Recipients of Blood Products and to Limit Deferral of Donors Transfusion Medicine and Hemotherapy · 2009